Covidien plc Income Statement

Ask AI

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2014 12 months to Sep 26, 2014	FY2013 12 months to Sep 27, 2013	FY2012 12 months to Sep 28, 2012	FY2011 12 months to Sep 30, 2011	FY2010 12 months to Sep 24, 2010
Net sales
Cost of goods sold
Gross profit
Selling, general and administrative expenses
Research and development expenses
Impairment of in-process research and development
Restructuring charges, net
Shareholder settlement (income) charges
Gain on divestiture, net
Operating income
Interest expense
Interest income
Other income, net
Income from continuing operations before income taxes
Income tax expense
Income from continuing operations
(Loss) income from discontinued operations, net of income taxes
Income from discontinued operations, net of income taxes
Net income
Basic earnings per share:
Income from continuing operations (in dollars per share)
Income from discontinued operations (in dollars per share)
Net income (in dollars per share)
Diluted earnings per share:
Income from continuing operations (in dollars per share)
Income from discontinued operations (in dollars per share)
Net income (in dollars per share)
Weighted-average number of shares outstanding:
Basic (in shares)
Diluted (in shares)

Comments